Market Overview

UPDATE: Jefferies Raises PT on CME Group on 1Q13 Exchange Preview

Share:
Related CME
What A Difference A Second Makes: Are Markets Prepared For Leap Second?
Oppenheimer Offers Deep Technical Dive Into Financials, Says Goldman, JP Morgan, Morgan Stanley 'Top Buy Ideas'
Give Yourself A Raise With These 5 Hot Income Stocks (Investor's Business Daily)

In a report published Monday, Jefferies analyst Daniel T. Fannon reiterated a Buy rating on CME Group (NASDAQ: CME), and raised the price target from $65.00 to $69.00.

In the report, Fannon noted, “We have lowered our 1Q13 EPS expectations for the traditional equity exchanges, while our numbers for the derivatives exchanges remain relatively unchanged. This mirrors the state of general industry trends, where the outlook for derivatives volume growth is much stronger than equity volume growth. CME and ICE remain our favorite ideas in the group.”

CME Group closed on Friday at $60.48.

Latest Ratings for CME

DateFirmActionFromTo
May 2015Evercore PartnersUpgradesHoldBuy
May 2015BarclaysMaintainsEqual-weight
May 2015Deutsche BankMaintainsBuy

View More Analyst Ratings for CME
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (CME)

Around the Web, We're Loving...